ERK1/2 pro‐survival signalling is suppressed by pirtobrutinib in ibrutinib‐resistant MYD88‐mutated lymphoma cells is a research paper published in British Journal of Haematology (2024). On theSindex it has a DataRank of 0. It has been cited 3 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Leukemia and Lymphoma Society
Grant: 6673‐24
Leukemia and Lymphoma Society
Grant: 6673-24
National Institutes of Health (USA)
Grant: 2P50CA100707-16A1
Dana Farber Cancer Institute and Eli Lilly, Inc.
International Waldenstrom's Macroglobulinemia Foundation
Fields of Study
MeSH Terms
Keywords